Pfizer’s mRNA flu shot outperforms standard flu vaccine in late-stage trial

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine.

The vaccine uses the same messenger RNA technology as Pfizer’s Covid…